MELISSA CALLAHAN: Open Payments
NPI 1669411393 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$47,200 in 132 payments from 8 companies in 2025. Trend: 2023 $9,494 · 2024 $5,977 · 2025 $47,200
Honoraria: $26,550Travel & lodging: $9,101Speaker / faculty: $6,970Food & beverage: $3,459Consulting: $1,120
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 97 | $36,881 |
| Alkermes, Inc. | 16 | $9,885 |
| Indivior Inc. | 8 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| ABBVIE INC. | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: BRIXADI, VIVITROL, SUBLOCADE, CAPLYTA, COBENFY, MAVYRET, Qelbree, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
